High-Dose-Rate Brachytherapy As Monotherapy for Prostate Cancer: A Meta-analysis of Biochemical Control Rates and Dose Fractionation
Tien C, Chen Z, Carlson D. High-Dose-Rate Brachytherapy As Monotherapy for Prostate Cancer: A Meta-analysis of Biochemical Control Rates and Dose Fractionation. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e621. DOI: 10.1016/j.ijrobp.2017.06.2099.Peer-Reviewed Original ResearchHDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials
Tien C, Carlson D, Nath R, Chen Z. HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials. Brachytherapy 2017, 16: s31. DOI: 10.1016/j.brachy.2017.04.038.Peer-Reviewed Original Research